Oxford University Innovation’s Clinical Outcomes manages the provision (licensing) and support of high quality clinical outcome assessments (COA) developed at the University of Oxford and elsewhere. The vast majority of our measures are Patient Reported Outcome (PRO) Measures (or sometimes referred to as PROMs).
We provide licences for some of the most respected and widely deployed outcome measures used by the pharmaceutical industry, healthcare providers, academia and medical device manufacturers.
The Clinical Outcomes team can also provide expert advice on the development and psychometric validation of new COAs and PROs, as well as the use of our own and other health outcome measures.
Clinical Outcomes will be promoting some new additions to their portfolio of diabetes outcome measures at ATTD in Berlin, Germany, 20th -23rd February!
The Oxford Cognitive Screen, a stroke-specific screening test, is now available in Danish and an alternative to the MoCA.
In addition to the original Ox-PAQ, an acute version is now available which asks participants to recall their experiences during a much shorter time period of 1 week, rather than 4.
